0000939767-16-000288.txt : 20161207 0000939767-16-000288.hdr.sgml : 20161207 20161207190349 ACCESSION NUMBER: 0000939767-16-000288 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161205 FILED AS OF DATE: 20161207 DATE AS OF CHANGE: 20161207 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 BUSINESS ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCANGOS GEORGE A CENTRAL INDEX KEY: 0001202102 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 162040152 MAIL ADDRESS: STREET 1: C/O EXELIXIS INC STREET 2: 170 HARBOR WAY CITY: SAN FRANCISCO STATE: CA ZIP: 94083 4 1 wf-form4_148115541665566.xml FORM 4 X0306 4 2016-12-05 0 0000939767 EXELIXIS, INC. EXEL 0001202102 SCANGOS GEORGE A C/O EXELIXIS, INC. 210 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2016-12-05 4 M 0 357976 8.99 A 1668186 D Common Stock 2016-12-05 4 S 0 204718 17.81 D 1463468 D Common Stock 2016-12-07 4 M 0 356 8.99 A 1463824 D Common Stock 2016-12-07 4 S 0 176 17.90 D 1463648 D Common Stock 8963 I By Trust (JS) Common Stock 8963 I By Trust (KS) Common Stock 5669 I By 401(k) Plan Option (right to buy) 8.99 2016-12-05 4 M 0 357976 0 D 2007-12-08 2016-12-07 Common Stock 357976.0 356 D Option (right to buy) 8.99 2016-12-07 4 M 0 356 0 D 2007-12-08 2016-12-07 Common Stock 356.0 0 D Includes 1,596 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.45 to $18.00. Reporting person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Jennifer Scangos Trust. Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Katherine Scangos Trust. Represents 5,669 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of December 2, 2016. The option, representing the right to purchase a total of 400,000 shares of Exelixis, Inc. common stock, became exercisable as to 100,000 shares on December 8, 2007, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the original grant date (December 8, 2006). The option ceased vesting on July 15, 2010, in connection with the Reporting Person's resignation as President and Chief Executive Officer of Exelixis, Inc., at which time the option was exercisable as to as to 358,332 shares of Exelixis, Inc. Common Stock. /s/ Jeffrey J. Hessekiel, Attorney in Fact 2016-12-07